Biotech firm Roivant Sciences to go public via $7.3bn SPAC deal From Forbes: Seven years ago, Vivek Ramaswamy created Roivant Sciences with the aim of finding a new financial model for drug development. On Monday, Roivant Sciences announced it would be going public by merging with a sp